Aterian prelim Q3 rev $63-67M, expects $24-29M goodwill impairment, closes $20M direct offering

Aterian, Inc.

Preliminary Q3 net revenue $63M-$67M; net loss expected due to operating loss and $24M-$29M non-cash goodwill impairment.
Goodwill impairment charge $24M-$29M due to stock price decline and reduced market cap; previous similar charge $29M in Q1 2022.
Closed registered direct offering of 10.64M shares + warrants for net ~$19.9M; priced at $1.90/unit for investors, $2.10 for insiders.
Resuming M&A strategy; intends to acquire a health & wellness brand, expected to be accretive without additional headcount.
Insider participation: CEO Yaniv Sarig, CFO Arturo Rodriguez, CLO Joe Risico, CTO Roi Zahut purchased units at $2.10 each.

item 1.01 item 2.02 item 2.06 item 8.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.